Fox Chase Cancer Center News

PHILADELPHIA (February 23, 2024) — Prior research has shown that delays in initiating cancer therapy are increasing, and these delays can lead to not only worse outcomes for patients, but also increased psychological distress. However, a new study published by researchers at Fox Chase Cancer Center has found that patients’ worry and fear can also contribute to their intentionally delaying the start of treatment.

PHILADELPHIA (February 22, 2024) — TFE3-rearranged renal cell carcinoma (rRCC) is a rare subtype of kidney cancer that can be misdiagnosed. This can affect treatment decisions and lead to patients receiving the wrong type of treatment. Now, a recently published study by scientists at Fox Chase Cancer Center identifies key genetic markers that can be used to distinguish rRCC from other cancers and also confirms which therapies are likely to be most effective. 

PHILADELPHIA (February 22, 2024) — Fox Chase Cancer Center is pleased to announce the hiring of Joyce G. Habib, MD, as an Assistant Professor in the breast medical oncology program in the Department of Hematology/Oncology.

PHILADELPHIA (February 19, 2024) — Stem cell transplant recipients can reduce their risk of Clostridioides difficile (C. diff) infection by taking the oral antibiotic vancomycin preventively, according to research from Fox Chase Cancer Center presented at a scientific meeting. However, the study also shows that taking this antibiotic can increase these patients’ risk of gram-negative bacteremia.

PHILADELPHIA (February 15, 2024) — Fox Chase Cancer Center is pleased to announce the hiring of Lilian Shin-Cho, PhD, as an Assistant Professor in the Cancer Prevention and Control Research Program.

PHILADELPHIA (February 13, 2024) — As part of a recently announced collaboration, Joshua Cohn, MD, FPMRS, an Associate Professor in the Department of Urology at Fox Chase Cancer Center and a member of the Fox Chase – Temple Urologic Institute, will serve as a consultant at Shriners Children’s Philadelphia. He will care for patients with neurogenic urologic conditions, in which a patient lacks bladder control due to injury, neurological disorders, or congenital malformations.

PHILADELPHIA (February 9, 2024) — Fox Chase Cancer Center is pleased to announce the hiring of Yash Chhabra, PhD, as an Assistant Professor in the Cancer Signaling and Microenvironment Research Program, where he will focus on the influence of sex disparity in cancer and aging.

PHILADELPHIA (February 2, 2024) — The Lewis Katz School of Medicine at Temple University is pleased to announce the hiring of Amina Abdul-Aziz, PhD, as an Assistant Professor at the Fels Cancer Institute for Personalized Medicine and new member of the Cancer Signaling and Microenvironment Research Program at Fox Chase Cancer Center.